Monte Rosa Therapeutics, Inc. (GLUE)

16.56 -0.67 (-3.89%) USD  |  NASDAQ  |  Dec 11, 16:00
16.57 +0.01 (+0.06%) Pre-Market: 08:59
More

Monte Rosa Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Novartis AG Upgrade
AVITA Medical, Inc. Upgrade
NanoVibronix, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Day One Biopharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade